SecSonar.com

Akanda Corp. (AKAN)

Akanda Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Akanda Corp. (AKAN) is a Drug Manufacturers - Specialty & Generic company based in GB with a market capitalization of $706.9K. Revenue declined 61.3% year-over-year and free cash flow was negative at -$6.1M. This page tracks AKAN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 46 employees · IPO Mar 15, 2022

Valuation

Valuation & price

$24.20 · as of May 26, 2026 · -74.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.17

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$87.20$44.79$2.38Jul 25Dec 25Jul 26Jul 7, 25$76.80Jul 9, 25$81.00Jul 11, 25$82.20Jul 15, 25$77.40Jul 17, 25$75.00Jul 21, 25$73.80Jul 23, 25$77.40Jul 25, 25$76.20Jul 29, 25$83.40Jul 31, 25$68.40Aug 4, 25$64.20Aug 6, 25$64.20Aug 11, 25$82.20Aug 13, 25$82.20Aug 15, 25$81.60Aug 19, 25$79.20Aug 21, 25$78.60Aug 25, 25$72.60Aug 27, 25$78.40Aug 29, 25$73.20Sep 3, 25$72.60Sep 5, 25$69.00Sep 9, 25$65.80Sep 11, 25$67.80Sep 16, 25$68.00Sep 18, 25$72.40Sep 22, 25$72.00Sep 24, 25$86.20Sep 26, 25$77.60Sep 30, 25$87.20Oct 2, 25$63.60Oct 6, 25$55.60Oct 8, 25$49.00Oct 10, 25$43.60Oct 14, 25$47.40Oct 16, 25$44.60Oct 21, 25$44.00Oct 23, 25$45.80Oct 27, 25$42.00Oct 29, 25$33.60Oct 31, 25$32.20Nov 4, 25$29.40Nov 6, 25$26.60Nov 10, 25$27.20Nov 12, 25$26.60Nov 14, 25$23.20Nov 18, 25$20.60Nov 20, 25$18.36Nov 25, 25$20.40Nov 28, 25$20.60Dec 2, 25$20.20Dec 4, 25$18.92Dec 8, 25$18.04Dec 10, 25$16.40Dec 12, 25$18.80Dec 16, 25$14.92Dec 18, 25$13.68Dec 22, 25$12.68Dec 24, 25$10.04Dec 29, 25$9.52Jan 2, 26$9.84Jan 6, 26$10.56Jan 8, 26$9.40Jan 12, 26$10.52Jan 14, 26$6.48Jan 16, 26$5.08Jan 21, 26$5.76Jan 23, 26$6.00Jan 27, 26$6.16Jan 29, 26$5.52Feb 2, 26$4.68Feb 4, 26$4.68Feb 9, 26$3.72Feb 11, 26$3.80Feb 13, 26$3.59Feb 18, 26$3.72Feb 20, 26$3.72Feb 24, 26$3.68Feb 26, 26$3.68Mar 2, 26$3.94Mar 4, 26$3.68Mar 6, 26$3.52Mar 10, 26$3.42Mar 12, 26$3.38Mar 17, 26$3.21Mar 19, 26$3.22Mar 23, 26$3.34Mar 25, 26$3.16Mar 27, 26$2.38Mar 31, 26$2.79Apr 2, 26$2.75Apr 7, 26$2.84Apr 9, 26$2.65Apr 13, 26$3.16Apr 15, 26$3.31Apr 17, 26$3.54Apr 22, 26$10.21Apr 24, 26$12.23Apr 28, 26$17.49Apr 30, 26$48.96May 4, 26$41.08May 6, 26$31.00May 8, 26$27.00May 12, 26$25.49May 14, 26$24.90May 18, 26$16.30May 20, 26$14.51May 22, 26$27.12May 28, 26$21.91Jun 1, 26$16.97Jun 3, 26$16.49Jun 5, 26$15.63Jun 9, 26$13.76Jun 11, 26$15.39Jun 15, 26$17.75Jun 17, 26$19.00Jun 22, 26$15.07Jun 24, 26$16.01Jun 26, 26$14.08Jul 2, 26$12.63
$2.3852-week range$95.40
Loading valuation history…

Fundamentals

Key fundamentals

$706.9K

Market cap

-61.3%

Revenue growth (YoY)

24.9%

Gross margin

-$6.1M

Free cash flow (USD)

-$3.5M

Net debt

Net cash position

151463.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2024

FY 2019$0.00FY 2020$2.1KFY 2021$41.4KFY 2022$2.6MFY 2023$2.2MFY 2024$836.7K
$0$836.7K

Free cash flow by year

2019 → 2024

FY 2019$-1.3MFY 2020$-1.8MFY 2021$-7.1MFY 2022$-11.8MFY 2023$-1.5MFY 2024$-6.1M
-$1.3M-$6.1M

Gross margin by year

2020 → 2024

FY 202012.3%FY 2021-1725.1%FY 2022124.8%FY 20235.2%FY 202424.9%
12.3%24.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Jun 18, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledJun 18, 2026Filing
  • Annual reportAnnual Report FiledJun 12, 2026Filing
  • Annual report20-F FiledJun 9, 2026Filing
  • 6-K filingRegulatory UpdateMay 22, 2026Filing
  • Annual reportAnnual Report FiledMay 13, 2026Filing
  • Annual reportAnnual Report FiledApr 29, 2026Filing
  • Annual reportAnnual Report FiledApr 10, 2026Filing
  • Annual reportAnnual Report FiledApr 9, 2026Filing
  • Annual reportAnnual Report FiledApr 7, 2026Filing
  • Annual reportAnnual Report FiledApr 2, 2026Filing

Questions

Frequently asked questions

What is Akanda Corp.'s market cap?

Akanda Corp. (AKAN) has a market capitalization of $706.9K.

What is AKAN's P/E ratio?

A meaningful P/E ratio is not available for AKAN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AKAN's price-to-book (P/B) ratio?

AKAN trades at 0.17 times book value per share.

Are insiders buying AKAN stock?

SEC Form 4 filings show no open-market insider buys at Akanda Corp. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

PRPH

ProPhase Labs, Inc.

$457.1K

IMCC

IM Cannabis Corp.

$1M

PRFX

PRF Technologies Ltd.

$368K

PTPI

Petros Pharmaceuticals, Inc.

$190.1K

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

SBFM

Sunshine Biopharma, Inc.

$1.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.